127 related articles for article (PubMed ID: 9438806)
21. Development of a preferential relationship with the mother by the newborn lamb: importance of the sucking activity.
Nowak R; Murphy TM; Lindsay DR; Alster P; Andersson R; Uvnäs-Moberg K
Physiol Behav; 1997 Oct; 62(4):681-8. PubMed ID: 9284484
[TBL] [Abstract][Full Text] [Related]
22. The effect of drugs acting on CCK receptors and rat free exploration in the exploration box.
Matto V; Harro J; Allikmets L
J Physiol Pharmacol; 1997 Jun; 48(2):239-51. PubMed ID: 9223028
[TBL] [Abstract][Full Text] [Related]
23. Functional role of brain CCK receptors.
Woodruff GN; Hill DR; Boden P; Pinnock R; Singh L; Hughes J
Neuropeptides; 1991 Jul; 19 Suppl():45-56. PubMed ID: 1881532
[No Abstract] [Full Text] [Related]
24. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
[TBL] [Abstract][Full Text] [Related]
25. Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze. Involvement of NMDA and CCK receptors.
Vasar E; Harro J; Lang A; Soosaar A; Oöpik T; Kôks S; Sihver S; Volke V
Eur Neuropsychopharmacol; 1993 Mar; 3(1):63-73. PubMed ID: 8471831
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic effects of CCK-B antagonists.
Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN
Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
[TBL] [Abstract][Full Text] [Related]
27. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
30. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Hughes J; Boden P; Costall B; Domeney A; Kelly E; Horwell DC; Hunter JC; Pinnock RD; Woodruff GN
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6728-32. PubMed ID: 1975695
[TBL] [Abstract][Full Text] [Related]
31. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
32. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat.
Matto V; Harro J; Allikmets L
J Physiol Pharmacol; 1996 Dec; 47(4):661-9. PubMed ID: 9116333
[TBL] [Abstract][Full Text] [Related]
33. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
34. CCK and development of mother preference in sheep: a neonatal time course study.
Nowak R; Breton G; Mellot E
Peptides; 2001 Aug; 22(8):1309-16. PubMed ID: 11457526
[TBL] [Abstract][Full Text] [Related]
35. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365,260.
Cooper SJ; Barber DJ
Brain Res Bull; 1990 Apr; 24(4):631-3. PubMed ID: 2141538
[TBL] [Abstract][Full Text] [Related]
36. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
Vasar E; Lang A; Harro J; Bourin M; Bradwejn J
Neuropharmacology; 1994 Jun; 33(6):729-35. PubMed ID: 7936110
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat.
Gaw AJ; Hills DM; Spraggs CF
Br J Pharmacol; 1995 Jun; 115(4):660-4. PubMed ID: 7582487
[TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
39. Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.
Adamec RE; Shallow T; Budgell J
Behav Neurosci; 1997 Apr; 111(2):435-49. PubMed ID: 9106682
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin receptor antagonists increase the rat pup's preference toward maternal-odor and rug texture.
Shayit M; Weller A
Dev Psychobiol; 2001 Apr; 38(3):164-73. PubMed ID: 11279593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]